User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 7 results.
    • Journal article
    Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
    Reginster, Jacques[UCL] Seeman, E De Vernejoul, MC Adami, S. Compston, J. Phenekos, C Devogelaer, Jean-Pierre[UCL] Curiel, MD Sawicki, A. Goemaere, S. Sorensen, OH Felsenberg, D. Meunier, PJ. (2005) Journal of Clinical Endocrinology and Metabolism — Vol. 90, no. 5, p. 2816-2822 (2005)
    • Journal article
    Effects of strontium ranelate on spinal osteoarthritis progression
    Bruyere, O. Delferriere, D. Roux, C. Wark, J. D. Spector, T. Devogelaer, Jean-Pierre[UCL] Brixen, K. Adami, S. Fechtenbaum, J. Kolta, S. Reginster, Jean-Yves (2008) Annals of the Rheumatic Diseases — Vol. 67, no. 3, p. 335-339 (2008)
    • Journal article
    Background for studies on the treatment of male osteoporosis: State of the art
    Kaufman, J.M. Fuchs, V. Kreutz, G. Nilsson, P. Pols, H. Ringe, J. Van Haelst, L. Reginster, J.Y. Johnell, O. Abadie, E. Adami, S. Audran, M. Avouac, B. Ben Sedrine, W. Calvo, G. Devogelaer, Jean-Pierre[UCL] (2000) Annals of the Rheumatic Diseases — Vol. 59, no. 10, p. 765-772 (2000)
    • Journal article
    Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial
    Reid, DM Hughes, RA Laan, RFJM Sacco-Gibson, NA Wenderoth, DH Adami, S. Eusebio, RA Devogelaer, Jean-Pierre[UCL] (2000) Journal of Bone and Mineral Research — Vol. 15, no. 6, p. 1006-1013 (2000)
    • Speech
    Dissociation between bone formation and bone resorption evidenced by changes in biochemical markers of bone turnover in patients treated with strontium ranelate
    Collette, J. Devogelaer, Jean-Pierre[UCL] Reginster, Jacques[UCL] Bruyere, O. Deroisy, R. Jupsin, I. Adami, S. Marcelli, C. (2007) 7th International Symposium on Osteoporosis — Washington (Dc)
    • Speech
    Risedronate is effective and well tolerated in treating corticosteroid-induced osteoporosis.
    Reid, D. Devogelaer, Jean-Pierre[UCL] Hughes, R Laan, R Adami, S. Sacco-Gibson, N Wenderoth, D (1998) —
    • Speech
    Strontium Ranelate Reduces the Risk of Vertebral and Non-vertebral Fractures in Caucasian Women With Post-menopausal Osteoporosis
    Adami, S. Devogelaer, Jean-Pierre[UCL] Meunier, P. J. Hoszowski, K. Fardellone, P. Benhamou, C. Brixen, K. Bonidan, O. Marcelli, C. Reginster, Jacques[UCL] Fechtenbaum, J. (2004) —